Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joette M Meyer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Gastroenterology|April 19, 2003
Use of lactoferrin for Helicobacter pylori eradicationJoette M Meyer
The New England Journal of Medicine|January 24, 2003
Helicobacter pyloriJoette M Meyer, Robert J Hopkins
Transplantation|February 6, 2013
FDA perspective: enrolment of elderly transplant recipients in clinical trialsJoette M Meyer, Patrick Archdeacon, Renata Albrecht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthraxAndrea Meyerhoff, Renata Albrecht, Joette M Meyer, et al.
Annals of Internal Medicine|January 5, 2002
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999Joette M Meyer, Nancy P Silliman, Wenjin Wang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Gastroenterology|April 19, 2003
Use of lactoferrin for Helicobacter pylori eradicationJoette M Meyer
The New England Journal of Medicine|January 24, 2003
Helicobacter pyloriJoette M Meyer, Robert J Hopkins
Transplantation|February 6, 2013
FDA perspective: enrolment of elderly transplant recipients in clinical trialsJoette M Meyer, Patrick Archdeacon, Renata Albrecht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthraxAndrea Meyerhoff, Renata Albrecht, Joette M Meyer, et al.
Annals of Internal Medicine|January 5, 2002
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999Joette M Meyer, Nancy P Silliman, Wenjin Wang, et al.
Pageof 1